{"url_path":"/sec/neo/8-k/2026-06-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000031-index.html","accession_number":"0001077183-26-000031","cik":"0001077183","ticker":"NEO","issuer_name":"NEOGENOMICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1077183/0001077183-26-000031-index.html","primary_entity_key":"0001077183","primary_entity_name":"NEOGENOMICS INC"},"word_count":90,"has_tables":true,"body_markdown":"Item 9.01\nFinancial Statements and Exhibits.\n\n(d)\n\nExhibits.\n\n[99.1](exhibit991-convertiblenote.htm)\n\n[Press release relating to the Pricing of the Convertible Note Offering issued by NeoGenomics, Inc. on June 17, 2026.](exhibit991-convertiblenote.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nNEOGENOMICS, INC.\n\nDate: June 17, 2026By:/s/ Alicia C. Olivo\n\nName:Alicia C. Olivo\n\nTitle:Executive Vice President, General Counsel & Secretary"}